Indian Experience with Vericiguat: A Review Based upon Case Series
No Thumbnail Available
Date
2024-10
Journal Title
Journal ISSN
Volume Title
Publisher
Journal of Indian Medical Association
Abstract
Heart failure (HF) is a condition that can result in repeated hospitalizations every year and can result in worsening HF (WHF). Although current pharmacological treatment for HF is fairly effective, there is a need to lower the residual risk of cardiovascular events and hospitalizations. Vericiguat, a soluble guanylate cyclase (sGC) stimulator, a new entrant, seems to present a promising therapeutic option for HF with signs of worsening, and early initiation of this therapy may be beneficial in certain patient profiles. This article explores the potential benefits of early vericiguat initiation in four patient profiles who presented with WHF.
Description
Keywords
Citation
Kaul Upendra, Dalal Jamshed, Hiremath Jagdish, Seth Sandeep, Mehta Ashwani, Juvale Nazir, Jariwala Pankaj V. Indian Experience with Vericiguat: A Review Based upon Case Series. Journal of the Association of Physicians of India. 2024 Oct; 72(10): 63–68